Titan Pharmaceuticals (NASDAQ:TTNP) Share Price Passes Below 200 Day Moving Average of $7.17

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.17 and traded as low as $7.01. Titan Pharmaceuticals shares last traded at $7.01, with a volume of 602 shares trading hands.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Titan Pharmaceuticals in a research note on Tuesday. They issued a “sell” rating for the company.

Titan Pharmaceuticals Stock Performance

The company has a market cap of $6.38 million, a P/E ratio of -0.85 and a beta of 1.33. The stock has a 50-day simple moving average of $7.34 and a 200 day simple moving average of $7.17.

About Titan Pharmaceuticals

Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union.